Labroots is excited to host the 7th Annual Event in the Bioprocessing Virtual Event Series on April 2nd, 2025! Bioprocessing, at its core, is the art and science of transforming raw materials into ...

Michael Stubblefield, CEO, highlighted Avantor's return to growth in Q4 2024 with low single-digit organic growth and strong bioprocessing performance, achieving high single-digit organic growth in ...

In terms of revenue, the global single-use bioprocessing market was valued at USD 32.52 billion in 2024 and is predicted to increase from 37.81 billion in 2025 to USD 146.84 billion by 2034. According ...

The global bioprocessing analytics equipment market is on the threshold of transformative growth, with recent projections anticipating a revenue increase from USD 485.1 million in 2022 to USD 633.6 ...

Manufacturing platforms for cell and gene therapies (CGT) are becoming more automated and integrated but, despite recent gains, there’s still a lot of room for improvement. The challenge is that ...

In line with this, global MedTech customers were stable in the quarter and the company experienced the first signs of increased bioprocessing demand. We expect this trend to have continued in the ...

This compares to the stock's 16.8% gain over the past four weeks. The company provides advanced bioprocessing technologies and solutions that are used by large biopharmaceutical companies and ...

META_DESC_INVESTMENT_IDEA ...

Bio-Techne Corporation (TECH) stock climbs as its Q2 FY25 results exceed Wall Street estimates amid recovery in the biopharma end market. Read more here.

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

The eruption of neo-Nazism and White Supremacy across the country has exposed the public to symbols, terms, and ideology drawn directly from Nazi Germany and Holocaust-era fascist movements. The ...